Mit freundlicher Genehmigung von DrugPatentWatch.com :
Drug Patentabläufe im September 2007
* Drugs können von mehr als einem Patent geschützt werden
| Handelsname | Antragsteller | Generic Name | Patent Nr. | Patentablauf |
| BETAXON | Alcon | Levobetaxolol Hydrochlorid | 4.911.920 | September 27,2007 |
| Betoptic S | Alcon | Betaxololhydrochlorid | 4.911.920 | September 27,2007 |
| CARDIOLITE | Bristol Myers Squibb | Technetium Tc-99m-Sestamibi-Kit | 4.885.100 | September 11,2007 |
| COGNEX | Sciele Pharma Inc | Tacrinhydrochlorid | 4.816.456 | September 09,2007 |
| COREG | Smithkline Beecham | Carvedilol | 4.503.067 | September 05,2007 |
| COREG CR | Sb Pharmco | Carvedilol Phosphat | 4.503.067 | September 05,2007 |
| MIRALUMA | Bristol Myers Squibb | Technetium Tc-99m-Sestamibi-Kit | 4.885.100 | September 11,2007 |
| NEXIUM | Astrazeneca | Esomeprazol Magnesium | 4.738.974 | September 01,2007 |
| Penlac | Sanofi Aventis uns | Ciclopirox | 4.957.730 | September 18,2007 |
| PULMICORT | Astrazeneca | Budesonid | 4.907.583 | September 13,2007 |
| TECZEM | Biovail | Diltiazem Malat; Enalaprilmaleat | 4.880.631 | September 24,2007 |
| TIAMATE | Merck | Diltiazem Malat | 4.880.631 | September 24,2007 |
Mit freundlicher Genehmigung von DrugPatentWatch.com

![[Facebook]](http://www.biotechblog.com/wp-content/plugins/bookmarkify/facebook.png)
![[Google]](http://www.biotechblog.com/wp-content/plugins/bookmarkify/google.png)
![[LinkedIn]](http://www.biotechblog.com/wp-content/plugins/bookmarkify/linkedin.png)
![[Twitter]](http://www.biotechblog.com/wp-content/plugins/bookmarkify/twitter.png)
![[Email]](http://www.biotechblog.com/wp-content/plugins/bookmarkify/email.png)












































